GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Dr Hoenle AG (HAM:HNL) » Definitions » Debt-to-EBITDA

Dr Hoenle AG (HAM:HNL) Debt-to-EBITDA : 6.59 (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Dr Hoenle AG Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Dr Hoenle AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €15.1 Mil. Dr Hoenle AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €40.7 Mil. Dr Hoenle AG's annualized EBITDA for the quarter that ended in Mar. 2024 was €8.5 Mil. Dr Hoenle AG's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 6.59.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Dr Hoenle AG's Debt-to-EBITDA or its related term are showing as below:

HAM:HNL' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -15.94   Med: 0.94   Max: 73.03
Current: -15.94

During the past 13 years, the highest Debt-to-EBITDA Ratio of Dr Hoenle AG was 73.03. The lowest was -15.94. And the median was 0.94.

HAM:HNL's Debt-to-EBITDA is ranked worse than
100% of 2279 companies
in the Industrial Products industry
Industry Median: 1.7 vs HAM:HNL: -15.94

Dr Hoenle AG Debt-to-EBITDA Historical Data

The historical data trend for Dr Hoenle AG's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Hoenle AG Debt-to-EBITDA Chart

Dr Hoenle AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.81 3.11 3.83 2.92 73.03

Dr Hoenle AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.59 -1.55 5.03 22.64 6.59

Competitive Comparison of Dr Hoenle AG's Debt-to-EBITDA

For the Electrical Equipment & Parts subindustry, Dr Hoenle AG's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Hoenle AG's Debt-to-EBITDA Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Dr Hoenle AG's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Dr Hoenle AG's Debt-to-EBITDA falls into.



Dr Hoenle AG Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Dr Hoenle AG's Debt-to-EBITDA for the fiscal year that ended in Sep. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(13.748 + 43.143) / 0.779
=73.03

Dr Hoenle AG's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(15.107 + 40.722) / 8.468
=6.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


Dr Hoenle AG  (HAM:HNL) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Dr Hoenle AG Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Dr Hoenle AG's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr Hoenle AG (HAM:HNL) Business Description

Traded in Other Exchanges
Address
Nicolaus-Otto-Street 2, Gilching, Munich, BY, DEU, 82205
Dr Hoenle AG supplies industrial UV technology. It operates in three business segments: The Equipment and Systems segment, which accounts for the majority of revenue, includes devices for UVC air and surface disinfection, and it is used for drying inks and coatings, for curing adhesives and plastics, and for solar simulation. The Glass and Lamps segment includes the development, production, and sale of tubing and semi-finished goods made of quartz glass as well as the manufacture of UV medium?pressure and low-pressure lamps. Adhesives segment, which includes industrial adhesives designed for a broad spectrum of applications such as electronics, medical technology, optics, and glass processing. The company generates the majority of its revenue from sales in other countries.

Dr Hoenle AG (HAM:HNL) Headlines

No Headlines